Andria R Morielli1, Nawaid Usmani2, Normand G Boulé1, Diane Severin2, Keith Tankel2, Tirath Nijjar2, Kurian Joseph2, Kerry S Courneya3. 1. Faculty of Physical Education and Recreation, University of Alberta, 1-113 University Hall, Edmonton, AB, T6G 2H9, Canada. 2. Department of Oncology, University of Alberta, Edmonton, AB, Canada. 3. Faculty of Physical Education and Recreation, University of Alberta, 1-113 University Hall, Edmonton, AB, T6G 2H9, Canada. kerry.courneya@ualberta.ca.
Abstract
PURPOSE: Aerobic exercise is safe and feasible for rectal cancer patients during and after neoadjuvant chemoradiotherapy (NACRT), but their motivation to perform such exercise is unknown. Here, we explore the motivational outcomes, perceived benefits and harms, and perceived barriers to exercise during and after NACRT. METHODS: Rectal cancer patients (n = 18) participated in supervised aerobic exercise during NACRT followed by unsupervised exercise after NACRT. Using the theory of planned behavior, we assessed perceived benefits, harms, enjoyment, support, difficulty, and barriers for exercise both during and after NACRT. RESULTS: Patients reported that exercise during NACRT was more enjoyable (p = 0.003) and less difficult (p = 0.037) than initially anticipated. The most common perceived benefits of exercise during NACRT were cardiovascular endurance (75 %), quality of life (75 %), and self-esteem (65 %). After NACRT, the most common perceived benefits were physical functioning (93 %), cardiovascular endurance (86 %), and quality of life (79 %). The most common perceived harms of exercise during NACRT were fatigue (31 %), diarrhea (31 %), and skin irritation (24 %). After NACRT, the most common perceived harms were fatigue (21 %) and hand-foot-syndrome (15 %). Side effects from NACRT were the most common exercise barrier during NACRT (88 %) whereas lack of motivation was the most common barrier after NACRT (79 %). CONCLUSIONS: Rectal cancer patients reported aerobic exercise during NACRT to be more enjoyable and less difficult than anticipated despite significant barriers. This positive motivational response may facilitate recruitment and adherence in future interventions. Moreover, rectal cancer patients identified potential benefits and harms that should be closely monitored in future interventions.
PURPOSE: Aerobic exercise is safe and feasible for rectal cancerpatients during and after neoadjuvant chemoradiotherapy (NACRT), but their motivation to perform such exercise is unknown. Here, we explore the motivational outcomes, perceived benefits and harms, and perceived barriers to exercise during and after NACRT. METHODS:Rectal cancerpatients (n = 18) participated in supervised aerobic exercise during NACRT followed by unsupervised exercise after NACRT. Using the theory of planned behavior, we assessed perceived benefits, harms, enjoyment, support, difficulty, and barriers for exercise both during and after NACRT. RESULTS:Patients reported that exercise during NACRT was more enjoyable (p = 0.003) and less difficult (p = 0.037) than initially anticipated. The most common perceived benefits of exercise during NACRT were cardiovascular endurance (75 %), quality of life (75 %), and self-esteem (65 %). After NACRT, the most common perceived benefits were physical functioning (93 %), cardiovascular endurance (86 %), and quality of life (79 %). The most common perceived harms of exercise during NACRT were fatigue (31 %), diarrhea (31 %), and skin irritation (24 %). After NACRT, the most common perceived harms were fatigue (21 %) and hand-foot-syndrome (15 %). Side effects from NACRT were the most common exercise barrier during NACRT (88 %) whereas lack of motivation was the most common barrier after NACRT (79 %). CONCLUSIONS:Rectal cancerpatients reported aerobic exercise during NACRT to be more enjoyable and less difficult than anticipated despite significant barriers. This positive motivational response may facilitate recruitment and adherence in future interventions. Moreover, rectal cancerpatients identified potential benefits and harms that should be closely monitored in future interventions.
Entities:
Keywords:
Cancer survivor; Chemotherapy; Exercise; Motivation; Radiotherapy; Theory of planned behavior
Authors: Shiraz I Mishra; Roberta W Scherer; Claire Snyder; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu Journal: Cochrane Database Syst Rev Date: 2012-08-15
Authors: Kerry S Courneya; Christine M Friedenreich; H Arthur Quinney; Anthony L A Fields; Lee W Jones; Jeffrey K H Vallance; Adrian S Fairey Journal: Ann Behav Med Date: 2005-04
Authors: Kerry S Courneya; Donald C McKenzie; Robert D Reid; John R Mackey; Karen Gelmon; Christine M Friedenreich; Aliya B Ladha; Caroline Proulx; Kirstin Lane; Jeffrey K Vallance; Roanne J Segal Journal: Ann Behav Med Date: 2008-02-20
Authors: Kerry S Courneya; Roanne J Segal; John R Mackey; Karen Gelmon; Robert D Reid; Christine M Friedenreich; Aliya B Ladha; Caroline Proulx; Jeffrey K H Vallance; Kirstin Lane; Yutaka Yasui; Donald C McKenzie Journal: J Clin Oncol Date: 2007-09-04 Impact factor: 44.544
Authors: Kerry S Courneya; Cynthia C Forbes; Linda Trinh; Christopher M Sellar; Christine M Friedenreich; Tony Reiman Journal: Clin Trials Date: 2013-08-05 Impact factor: 2.486
Authors: M A West; L Loughney; D Lythgoe; C P Barben; R Sripadam; G J Kemp; M P W Grocott; S Jack Journal: Br J Anaesth Date: 2014-10-01 Impact factor: 9.166
Authors: Camila S Padilha; Poliana Camila Marinello; Daniel A Galvão; Robert U Newton; Fernando H Borges; Fernando Frajacomo; Rafael Deminice Journal: J Cancer Surviv Date: 2017-01-04 Impact factor: 4.442
Authors: Martina Ferioli; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Simona Ultimo; Silvano Capitani; Luca M Neri Journal: Oncotarget Date: 2018-02-08
Authors: Lisa Loughney; Malcolm A West; Michael P W Grocott; Sandy Jack; Helen Moyses; Andrew Bates; Graham J Kemp; Lesley Hawkins; Judit Varkonyi-Sepp; Shaunna Burke; Christopher P Barben; Peter M Calverley; Trevor Cox; Daniel H Palmer; Michael G Mythen Journal: Perioper Med (Lond) Date: 2021-06-22